Latest Breaking News On - Domiphen bromide - Page 1 : comparemela.com

Hyloris and Purna Female Healthcare Announce Positive Results from Phase 2 Trial in Patients with Acute Vulvovaginal Candidiasis (VVC) Both treatment arms with the combination of Miconazole (2%) and Domiphen Bromide (0.14% or 0.29%) demonstrated excellent safety and tolerability Low dose (0.14%) showed significant improvement over active control in clinical and mycological outcome at day 291 Liège, Belgium – 30 January 2024, 07:00 AM CET – Regulated information – Inside information – Hyloris Pha

Miconazole domiphenJean luc vandebroekStijn van rompayHyloris pharmaceuticalsPurna pharmaceuticalsHyloris pharmaceuticals sa euronext brusselsPurna female healthcare announce positive resultsAcute vulvovaginal candidiasisDomiphen bromideEuronext brusselsMiconazole domiphen bromideVan rompayChief executive officerFemale healthcareLuc vandebroekLancet infectious diseases